Dunlop NM - Search Results

1

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.

Profy AT, Salinas PA, Eckler LI, Dunlop NM, Nara PL, Putney SD. Profy AT, et al. Among authors: dunlop nm. J Immunol. 1990 Jun 15;144(12):4641-7. J Immunol. 1990. PMID: 1693639

2

Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.

Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA. Ahlers JD, et al. J Immunol. 1993 Jun 15;150(12):5647-65. J Immunol. 1993. PMID: 8515081

3

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS. Haigwood NL, et al. J Virol. 1992 Jan;66(1):172-82. doi: 10.1128/JVI.66.1.172-182.1992. J Virol. 1992. PMID: 1727480 Free PMC article.

4

Cross-neutralizing antibodies to HIV-1 in mice after immunization with gp160 iscoms. Dissection of the immune response.

Akerblom L, Nara P, Dunlop N, Morein B. Akerblom L, et al. AIDS Res Hum Retroviruses. 1991 Jul;7(7):621-7. doi: 10.1089/aid.1991.7.621. AIDS Res Hum Retroviruses. 1991. PMID: 1768464

5

HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.

Akerblom L, Nara P, Dunlop N, Putney S, Morein B. Akerblom L, et al. Biotechnol Ther. 1993;4(3-4):145-61. Biotechnol Ther. 1993. PMID: 8292967

6

Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.

Nara P, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Krone W, Goudsmit J. Nara P, et al. Dev Biol Stand. 1990;72:315-41. Dev Biol Stand. 1990. PMID: 2282990

7

In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.

Barbas CF 3rd, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL, Burton DR. Barbas CF 3rd, et al. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3809-13. doi: 10.1073/pnas.91.9.3809. Proc Natl Acad Sci U S A. 1994. PMID: 8170992 Free PMC article.

8

Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.

Ahlers JD, Dunlop N, Pendleton CD, Newman M, Nara PL, Berzofsky JA. Ahlers JD, et al. AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):259-72. doi: 10.1089/aid.1996.12.259. AIDS Res Hum Retroviruses. 1996. PMID: 8906986

9

Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.

Ahlers JD, Dunlop N, Alling DW, Nara PL, Berzofsky JA. Ahlers JD, et al. J Immunol. 1997 Apr 15;158(8):3947-58. J Immunol. 1997. PMID: 9103465

10

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.

Nara PL, Robey WG, Pyle SW, Hatch WC, Dunlop NM, Bess JW Jr, Kelliher JC, Arthur LO, Fischinger PJ. Nara PL, et al. Among authors: dunlop nm. J Virol. 1988 Aug;62(8):2622-8. doi: 10.1128/JVI.62.8.2622-2628.1988. J Virol. 1988. PMID: 3392769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters